Bioarmor87 vs Clive | 17–39 | 30.36% |
Bioarmor87 vs King | 24–25 | 48.98% |
Bioarmor87 vs Jin | 23–26 | 46.94% |
Bioarmor87 vs Law | 29–19 | 60.42% |
Bioarmor87 vs Heihachi | 18–27 | 40.00% |
Bioarmor87 vs Kazuya | 16–28 | 36.36% |
Bioarmor87 vs Hwoarang | 23–19 | 54.76% |
Bioarmor87 vs Jun | 14–22 | 38.89% |
Bioarmor87 vs Steve | 20–14 | 58.82% |
Bioarmor87 vs Bryan | 15–16 | 48.39% |
Bioarmor87 vs Eddy | 11–18 | 37.93% |
Bioarmor87 vs Dragunov | 10–17 | 37.04% |
Bioarmor87 vs Reina | 15–10 | 60.00% |
Bioarmor87 vs Yoshimitsu | 8–16 | 33.33% |
Bioarmor87 vs Paul | 7–16 | 30.43% |
Bioarmor87 vs Nina | 8–14 | 36.36% |
Bioarmor87 vs Lili | 7–12 | 36.84% |
Bioarmor87 vs Devil Jin | 7–9 | 43.75% |
Bioarmor87 vs Victor | 5–10 | 33.33% |
Bioarmor87 vs Leo | 9–5 | 64.29% |
Bioarmor87 vs Azucena | 8–6 | 57.14% |
Bioarmor87 vs Lee | 6–6 | 50.00% |
Bioarmor87 vs Raven | 6–6 | 50.00% |
Bioarmor87 vs Xiaoyu | 7–4 | 63.64% |
Bioarmor87 vs Lars | 5–6 | 45.45% |
Bioarmor87 vs Lidia | 4–7 | 36.36% |
Bioarmor87 vs Jack-8 | 5–3 | 62.50% |
Bioarmor87 vs Asuka | 2–5 | 28.57% |
Bioarmor87 vs Feng | 3–4 | 42.86% |
Bioarmor87 vs Kuma | 2–4 | 33.33% |
Bioarmor87 vs Alisa | 2–3 | 40.00% |
Bioarmor87 vs Claudio | 1–4 | 20.00% |
Bioarmor87 vs Shaheen | 1–2 | 33.33% |
Bioarmor87 vs Panda | 0–2 | 0.00% |
Bioarmor87 vs Zafina | 2–0 | 100.00% |
Bioarmor87 vs Leroy | 2–0 | 100.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.